Evidence map›Paper›PMID 35942939›Full record

ArticleeLife2022

Temporal analysis of enhancers during mouse cerebellar development reveals dynamic and novel regulatory functions.

Miguel Ramirez, Yuliya Badayeva, Joanna Yeung, Joshua Wu, Ayasha Abdalla-Wyse, Erin Yang, FANTOM 5 Consortium, Brett Trost, Stephen W Scherer, Daniel Goldowitz

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Miguel RamirezCentre for Molecular Medicine and Therapeutics, BC Children's Hospital Research Institute, Vancouver, Canada.ORCID 0000-0001-6315-4291
Yuliya BadayevaCentre for Molecular Medicine and Therapeutics, BC Children's Hospital Research Institute, Vancouver, Canada.
Joanna YeungCentre for Molecular Medicine and Therapeutics, BC Children's Hospital Research Institute, Vancouver, Canada.ORCID 0000-0003-0551-5305
Joshua WuCentre for Molecular Medicine and Therapeutics, BC Children's Hospital Research Institute, Vancouver, Canada.
Ayasha Abdalla-WyseCentre for Molecular Medicine and Therapeutics, BC Children's Hospital Research Institute, Vancouver, Canada.
Erin YangCentre for Molecular Medicine and Therapeutics, BC Children's Hospital Research Institute, Vancouver, Canada.ORCID 0000-0001-5629-2362
FANTOM 5 ConsortiumRIKEN, Wako, Japan.
Brett TrostThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Canada.ORCID 0000-0003-4863-7273
Stephen W SchererThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Canada.ORCID 0000-0002-8326-1999
Daniel GoldowitzCentre for Molecular Medicine and Therapeutics, BC Children's Hospital Research Institute, Vancouver, Canada.ORCID 0000-0003-4756-4017
University of British Columbia · CAGreat Ormond Street Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have identified active enhancers in the mouse cerebellum at embryonic and postnatal stages which provides a view of novel enhancers active during cerebellar development. The majority of cerebellar enhancers have dynamic activity between embryonic and postnatal development. Cerebellar enhancers were enriched for neural transcription factor binding sites with temporally specific expression. Putative gene targets displayed spatially restricted expression patterns, indicating cell-type specific expression regulation. Functional analysis of target genes indicated that enhancers regulate processes spanning several developmental epochs such as specification, differentiation and maturation. We use these analyses to discover one novel regulator and one novel marker of cerebellar development: Bhlhe22 and Pax3, respectively. We identified an enrichment of de novo mutations and variants associated with autism spectrum disorder in cerebellar enhancers. Furthermore, by comparing our data with relevant brain development ENCODE histone profiles and cerebellar single-cell datasets we have been able to generalize and expand on the presented analyses, respectively. We have made the results of our analyses available online in the Developing Mouse Cerebellum Enhancer Atlas, where our dataset can be efficiently queried, curated and exported by the scientific community to facilitate future research efforts. Our study provides a valuable resource for studying the dynamics of gene expression regulation by enhancers in the developing cerebellum and delivers a rich dataset of novel gene-enhancer associations providing a basis for future in-depth studies in the cerebellum.

Indexed as

Autism Spectrum DisorderEnhancer Elements, GeneticAnimalsGene Expression Regulation, DevelopmentalMiceNeurogenesisTranscription FactorsTranscription Factorsbrain developmentcerebellumdevelopmental biologyenhancersepigeneticsgene expression regulationmouseneurosciencetranscription factors

Identifiers

PMID35942939
PMCPMC9398453
OpenAlexW4292360269

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.